trophogen's research is focused on developing superagonists and antagonists of cystine knot growth factors. our platform technology of substituting amino acids in protein sequences based on electrostatic interactions has implications in a variety of therapeutic fields from infertility to cancer.

Trophogen Cancer Anti Cancer Drugs Cancer Treatment Ovarian Cancer Thyroid Cancer Cancer Targeting Cancer Visualisation Glycoprotein Hormones Glycoproteins Super Active Hormones Protein Analogs Superagonists Protein Therapeutics Drug Discovery Rational Drug Design Growth Factors Gonadotropins Cystine Knot Growth Factors Recombinant Hormones Enhancing Nature Biotechnology Maryland Biotech Hormone Evolution

Electrostatic Interactions In Hormones Thyrogen Thyroid Stimulating Hormone Follicle Stimulating Hormone Luteinizing Hormone Start-up Biotech Infertility Drugs Recombinant Glycoproteins In Vitro Fertilization Fertility Hormones Protein Evolution Protein Technology Private Sector Biotechnology Structure-function Studies Recombinant Tsh Recombinant Fsh Recombinant Lh Superactive Analogs Glycoprotein Engineering Hormone Engineering Glycoprotein Analogs Protein Engineering Local Biotechnology Nih License

Contact:	301-838-1935 x101
Address:	6 Taft Ct Ste 150 Rockville, Maryland   20850-5361 , USA
Url:	http://www.trophogen.com
Fax:	301-762-6287
Year Established:	2001
Annual Sales:	Below US$1 Million
Business Type:	Service